...
首页> 外文期刊>Cell and Tissue Research >The triggering receptor expressed by myeloid cells-1 activates TLR4-MyD88-NF-κB-dependent signaling to aggravate ventilation-induced lung inflammation and injury in mice
【24h】

The triggering receptor expressed by myeloid cells-1 activates TLR4-MyD88-NF-κB-dependent signaling to aggravate ventilation-induced lung inflammation and injury in mice

机译:由髓细胞表达的触发受体-1激活TLR4-MYD88-NF-κB依赖的信号,以加剧通风诱导的肺炎症和小鼠损伤

获取原文
获取原文并翻译 | 示例
           

摘要

The triggering receptor expressed by myeloid cells-1 (TREM-1) plays an important role in infectious and autoimmune diseases but how it contributes to ventilation-induced lung injury (VILI) and inflammation is unclear. Here, we examine the possibility that TREM-1 activates signaling dependent on Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (Myd88) and nuclear factor (NF)-κB, which leads in turn to VILI. In a mouse model of VILI, which we validated based on lung edema and histopathology as well as cytokine levels, we examine mRNA and protein levels of TREM-1, TLR4, MyD88, NF-κB and its inhibitory protein I-κB in animals subjected to ventilation at normal or high tidal volume. The extent of lung edema, injury and inflammation were higher in the high tidal volume animals, as were the expression levels of all proteins examined. Treatment with TREM-1 agonist aggravated these effects, whereas treatment with TREM-1 antagonist attenuated them. Our results suggest that aggravation of VILI by TREM-1 in mice may be associated with TLR4-MyD88-NF-κB-dependent signaling.
机译:髓样细胞1(TREM-1)表达的触发受体在感染性和自身免疫性疾病中起着重要作用,但其如何导致通气诱导的肺损伤(VILI)和炎症尚不清楚。在这里,我们研究了TREM-1激活依赖于Toll样受体4(TLR4)、髓样分化因子88(Myd88)和核因子(NF)-κB的信号传导的可能性,这反过来导致VILI。在我们根据肺水肿、组织病理学以及细胞因子水平验证的VILI小鼠模型中,我们检测了正常或大潮气量通气动物体内TREM-1、TLR4、MyD88、NF-κB及其抑制蛋白I-κB的mRNA和蛋白质水平。在大潮气量动物中,肺水肿、损伤和炎症的程度更高,所检测的所有蛋白质的表达水平也更高。用TREM-1激动剂治疗会加重这些效应,而用TREM-1拮抗剂治疗则会减弱这些效应。我们的结果表明,TREM-1对小鼠VILI的加重可能与TLR4-MyD88-NF-κB依赖性信号有关。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号